Risk Management

ASOPRS 2023 Meeting in Quebec City, Canada, during June 22-25, 2023

June 22, 2023 – June 25, 2023 all-day
Fairmont Le Chateau Frontenac
1 Rue des Carrières
Québec, QC G1R 4P5
Contact ASOPRS
ASOPRS 2023 Meeting in Quebec City, Canada, during June 22-25, 2023 @ Fairmont Le Chateau Frontenac | Québec | Québec | Canada

The 2023 Spring ASOPRS Meeting (American Society of Ophthalmic Plastic & Reconstructive Surgery) is planned for June 22 to June 25, 2023 at the Fairmont Le Chateau Frontenac. This meeting is open to current members of ASOPRS or ASOPRS Candidate Members.


Date of OMIC presentation:   Saturday, June 24, 2023

Time of presentation: 11:00 am to 11:45 am

Location: Fairmont Le Chateau Frontenac, Quebec City, Quebec, Canada

Topic:  Managing the Unhappy Patient

Panelists: Tamara R. Fountain, MD, former OMIC Board Chair and Linda D. Harrison, PhD, vice-president, OMIC Risk Management along with Elizabeth Bradley, MD, Ted Wojno, MD, Keith Carter, MD, and Don Kikkawa, MD.

The ASOPRS website updates information regularly:


OMIC insureds/ASOPRS members who attend this course will earn a policy discount!  Be sure to sign in while in the presentation room to ensure your OMIC discount.

In Person Registration Includes: Admission to all Scientific Sessions, Friday, Saturday and Sunday breakfasts and breaks, President’s Welcome Reception (Thursday) and the Annual Banquet/New Member Inductions (Saturday).

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Comments are closed.

Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.